Thomas Adams - Jul 1, 2022 Form 3/A - Amendment Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Interim CFO
Signature
/s/ Stephen Unger, Attorney-in-Fact
Stock symbol
KRMD
Transactions as of
Jul 1, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
4/18/2023, 04:15 PM
Date Of Original Report
Jul 21, 2022
Next filing
Aug 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding KRMD Common Stock 0 Jul 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KRMD Option to Purchase Shares of Common Stock Jul 1, 2022 Common Stock 200K $3.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 12/01/2021 date of grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.

Remarks:

This Form 3/A Amendment No. 1 is being filed to include the Reporting Person's Option to Purchase Shares of Common Stock in Table II, which were inadvertently omitted on the original Form 3 filing. The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.